Market Closed -
Australian S.E.
02:10:04 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
1.21
AUD
|
+1.26%
|
|
+7.56%
|
-17.69%
|
Fiscal Period: June |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
447.4
|
740.1
|
679.1
|
-
|
-
|
Enterprise Value (EV)
1 |
467
|
1,436
|
1,139
|
1,154
|
1,181
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
Yield
|
5.45%
|
5.8%
|
6.71%
|
7.07%
|
7.55%
|
Capitalization / Revenue
|
15.4
x
|
15.5
x
|
9.18
x
|
8.08
x
|
7.37
x
|
EV / Revenue
|
16
x
|
30.1
x
|
15.4
x
|
13.7
x
|
12.8
x
|
EV / EBITDA
|
24.5
x
|
48.5
x
|
18
x
|
17.2
x
|
16.3
x
|
EV / FCF
|
19.8
x
|
63.3
x
|
256
x
|
38.5
x
|
-24.7
x
|
FCF Yield
|
5.05%
|
1.58%
|
0.39%
|
2.59%
|
-4.05%
|
Price to Book
|
0.68
x
|
0.78
x
|
0.7
x
|
0.69
x
|
0.68
x
|
Nbr of stocks (in thousands)
|
325,378
|
562,814
|
568,306
|
-
|
-
|
Reference price
2 |
1.375
|
1.315
|
1.195
|
1.195
|
1.195
|
Announcement Date
|
8/11/22
|
8/14/23
|
-
|
-
|
-
|
Fiscal Period: June |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
29.14
|
47.7
|
73.99
|
84
|
92.2
|
EBITDA
1 |
19.1
|
29.6
|
63.39
|
67.13
|
72.57
|
EBIT
1 |
17.47
|
29.6
|
62.34
|
64.96
|
67.91
|
Operating Margin
|
59.94%
|
62.05%
|
84.25%
|
77.33%
|
73.66%
|
Earnings before Tax (EBT)
|
49.61
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
20.2
|
30.7
|
78.2
|
91.2
|
Net margin
|
-
|
42.35%
|
41.49%
|
93.1%
|
98.92%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
23.59
|
22.7
|
4.45
|
29.95
|
-47.85
|
FCF margin
|
80.95%
|
47.59%
|
6.01%
|
35.65%
|
-51.9%
|
FCF Conversion (EBITDA)
|
123.49%
|
76.69%
|
7.02%
|
44.61%
|
-
|
FCF Conversion (Net income)
|
-
|
112.38%
|
14.5%
|
38.3%
|
-
|
Dividend per Share
2 |
0.0750
|
0.0762
|
0.0802
|
0.0844
|
0.0902
|
Announcement Date
|
8/11/22
|
8/14/23
|
-
|
-
|
-
|
Fiscal Period: June |
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
---|
Net sales
1 |
10.84
|
18.29
|
-
|
-
|
39.6
|
EBITDA
1 |
-
|
-
|
-
|
18.4
|
29.1
|
EBIT
1 |
4.423
|
11.39
|
10.6
|
18.4
|
29.1
|
Operating Margin
|
40.79%
|
62.25%
|
-
|
-
|
73.48%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
1.542
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
0.004700
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.0388
|
-
|
Announcement Date
|
2/17/22
|
8/11/22
|
2/16/23
|
8/14/23
|
2/12/24
|
Fiscal Period: June |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
19.6
|
696
|
460
|
475
|
502
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.026
x
|
23.52
x
|
7.255
x
|
7.078
x
|
6.913
x
|
Free Cash Flow
1 |
23.6
|
22.7
|
4.45
|
30
|
-47.9
|
ROE (net income / shareholders' equity)
|
2.42%
|
2.52%
|
4.77%
|
5.08%
|
5.4%
|
ROA (Net income/ Total Assets)
|
-
|
1.67%
|
2.6%
|
3.27%
|
3.91%
|
Assets
1 |
-
|
1,209
|
1,183
|
2,391
|
2,334
|
Book Value Per Share
2 |
2.010
|
1.690
|
1.700
|
1.730
|
1.760
|
Cash Flow per Share
2 |
0.0700
|
0.0600
|
0.0400
|
0.0700
|
0.0800
|
Capex
1 |
-
|
-
|
18.3
|
41.6
|
68.8
|
Capex / Sales
|
-
|
-
|
24.73%
|
49.52%
|
74.62%
|
Announcement Date
|
8/11/22
|
8/14/23
|
-
|
-
|
-
|
Last Close Price
1.195
AUD Average target price
1.506
AUD Spread / Average Target +26.00% Consensus |
1st Jan change
|
Capi.
|
---|
| -17.69% | 443M | | +4.62% | 55.76B | | -11.72% | 17.72B | | -5.05% | 13.23B | | +1.40% | 7.68B | | -17.93% | 5.39B | | +8.62% | 3.28B | | -2.31% | 3.23B | | -3.93% | 3.06B | | +12.61% | 2.73B |
Healthcare REITs
|